MassDevice.com +5 | The top 5 medtech stories for March 29, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. The exodus of key personnel at Google’s Verily There’s reportedly a rare exodus under way of key personnel from a Google operation, its Verily healthcare “moonshot,” with former employees blaming the mercurial leadership of CEO Andrew Conrad. A dozen top engineers, scientists and managers have departed since Verily, formerly Google Life Sciences, was launched 3 years ago, according to the Stat website. Read more 4. Report: U.S. IPOs hit 7-year low during 2016 1st quarter The U.S. market for initial public offerings hit its lowest mark during the 1st quarter since the financial crisis hit in 2008 and 2009 and every flotation was for a healthcare company, according to a report from Renaissance Capital. Eight IPOs raised a collective $700 million during the quarter, but were only viable due to substantial buys from existing shareholders, according to the report. Read more 3. St. Jude wins CE Mark for expanded suite of cardiac leads St. Jude Medical said today it won CE Mark approval in the European Union and launched 3 new Quartet left ventricular leads. The newly releas...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news